The boundary between science fiction and medical reality blurs as companies like Elon Musk's Neuralink make strides in ...

The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...

Neuralink, Elon Musk’s brain-computer venture, and rivals like Max Hodak’s Science, are chasing advances in technology that ...

Michael Mager of Precision Neuroscience, a brain implant startup rival to Elon Musk's Neuralink, sounds off on the future of ...

Neuralink has claimed in a tweet that it has finally received approval from the FDA to start a first-in-human clinical trial of its brain implant chip – but hasn’t indicated when it may start.

Elon Musk's brain chip firm Neuralink has said that the US Food and Drug Administration (FDA) has approved its first human clinical trial, a critical milestone after earlier struggles to gain ...

Elon Musk's Neuralink has been awarded breakthrough status from the FDA for an implantable chip – dubbed Blindsight – that promises to restore the sight of people with vision impairment.

Musk has business interests that depend heavily on government regulation, subsidies or policy, from Tesla’s electric cars to ...

Michelle Tarver, MD, PhD, a 15-year veteran of the agency, is stepping into a pivotal role as the new director of the FDA's device division, taking over for Jeffrey Shuren, MD. Dr. Shuren's tenure was ...

Disruptedcategory Musk's Neuralink gets FDA's breakthrough device tag for 'Blindsight' implant September 18, 2024 Healthcare & Pharmaceuticalscategory Musk's Neuralink says second trial implant ...

Novo Nordisk has asked the FDA to block production of compounded copies of Ozempic, arguing that it’s too difficult to do safely. It’s the latest escalation in a brewing war between pharmaceutical ...

The US Food and Drug Administration (FDA) has awarded a "Breakthrough Device" status to Neuralink’s experimental vision-restoring implant, Blindsight. This designation is intended to fast-track ...